FDA Issues 4th Oyster Warning In 18 Days
Trump's staff is laying the groundwork to prepare for a new FDA commissioner and make their mark at the agency.
The Food and Drug Administration said that consumers should avoid eating the possibly norovirus-contaminated oysters and a batch of broccoli possibly contaminated with listeria.
CNBC's Becky Quick reports on news from Eli Lilly. US surgeon general urges cancer warnings for alcoholic drinks 14 Trader Joe's Items That Have Gained a Cult Following for a Good Reason
In October, the FDA in collaboration with the U.S. Customs and Border Protection (CBP), seized about three million units of unauthorized e-cigarette products, with an estimated retail value of $76 million. The products included various brands of illegal e-cigarettes, including Geek Bar.
A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation of the Food and Drug Administration (FDA).
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the
With Donald Trump taking office and Robert F. Kennedy Jr. poised to assume the nation’s top health role, it seems the agency is on the precipice of a big shake-up. Kennedy has floated loosening regulation on raw milk, more harshly scrutinizing the safety of vaccines, and cracking down on ultra-processed foods and additives.
After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking to protect its investment by wading into a lawsuit that seeks to allow | After plugging $23 billion into its manufacturing network to meet rampant demand for Mounjaro and Zepbound,
The FDA and Alcon Laboratories recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count over fungal contamination.
The Food and Drug Administration (FDA) will begin collecting samples of raw cow’s milk cheese from across the U.S. to test for the presence of bird flu, spurred on by the ongoing outbreaks
FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.